Free Trial

Brooklyn ImmunoTherapeutics (BTX) SEC Filings & 10K Form

Brooklyn ImmunoTherapeutics logo
$0.25 +0.00 (+1.05%)
(As of 12/20/2024 ET)

Recent Brooklyn ImmunoTherapeutics SEC Filings

DateFilerForm TypeView
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/17/2024
11:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/05/2024
11:42 AM
Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
09/27/2024
3:47 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
09/27/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
3:32 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:14 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:30 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-K/A
02/16/2024
4:30 PM
Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2024
6:30 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
6:05 AM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SC 13G/A
01/22/2024
11:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
01/19/2024
9:31 AM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Singer Nicholas Jason (Filed by)
Form SC 13G/A
01/12/2024
3:49 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/22/2023
11:05 AM
Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:BTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners